- Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions - https://eyedocnews.com -

RetroSense Using Optogenetics to Treat Retinitis Pigmentosa and Dry AMD

Posted By Irv Arons On April 4, 2013 @ 12:06 pm In Industry News,Macular Degeneration,New Technologies,Retina | Comments Disabled

RetroSense is a biotechnology company using optogenetic approaches to treat retinal diseases such as retinitis pigmentosa and dry AMD.

Optogenetics refers to a technique for restoring vision that uses “opsins” to genetically convert retinal cells that were not previously, or natively light sensitive to become light sensitive, and thereby mimic the function of rods and cones.

For example, patients with retinitis pigmentosa experience progressive and irreversible vision loss because the rods and cones of their eyes die. Retrosense’s technique allows other cells in the retina (e.g., ganglion cells) to take the place of the rods and cones.

To read more, please follow this link [1].


Article printed from Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions: https://eyedocnews.com

URL to article: https://eyedocnews.com/007079-retrosense-using-optogenetics-to-treat-retinitis-pigmentosa-and-dry-amd/

URLs in this post:

[1] link: http://tinyurl.com/GeneTherapy18

Copyright © 2008 Eye Doc Talk. All rights reserved.